Boston Scientific Expects Taxus Inventory, Sales To Reach Pre-Recall Levels

Boston Scientific's Taxus drug-eluting stent inventory will climb 13% to 166,000 in October from 147,000 in September as the firm works to rebuild stock in the wake of a summer recall